Aptose Biosciences
APTO
#10464
Rank
S$5.66 M
Marketcap
S$2.22
Share price
0.00%
Change (1 day)
727.28%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -S$9.6 Million

According to Aptose Biosciences's latest financial reports the company has -S$9.6 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-S$3.84 Million-107.57%
2022-12-31$S$50.59 M-49.59%
2021-12-31$S$0.10 B-36.21%
2020-12-31$S$0.15 B24.23%
2019-12-31$S$0.12 B558.27%
2018-12-31$S$19.23 M40.98%
2017-12-31$S$13.64 M28.66%
2016-12-31$S$10.6 M-45.08%
2015-12-31$S$19.3 M
2014-05-31$S$32.87 M-3549.38%
2013-05-31$-S$0.96 Million-62.39%
2012-05-31$-S$2.54 Million-940.62%
2011-05-31$S$0.3 M-141.56%
2010-05-31$-S$0.73 Million-93.43%
2009-05-31$-S$11.05 Million109.35%
2008-05-31$-S$5.28 Million-584.66%
2007-05-31$S$1.08 M-129.66%
2006-05-31$-S$3.67 Million-120.69%
2005-05-31$S$17.73 M-50.43%
2004-05-31$S$35.79 M-1.53%
2003-05-31$S$36.34 M-29.6%
2002-05-31$S$51.63 M-21.6%
2001-05-31$S$65.86 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-S$31.69 Million 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
S$0.14 B-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
S$0.72 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA